| 中文别名 |
利奈唑胺;利奈唑烷(吗啉恶酮);吗啉恶酮(雷奈佐利, 利奈唑胺,利奈唑烷,利奈唑 );利奈唑胺,雷奈佐利;利萘唑酮及中间体;利萘唑胺;利萘唑酮;利奈唑胺-13C-D3;雷奈佐利;Linezolid 利奈唑酮;雷奈佐利 技术转让;雷奈佐利(利奈唑胺);雷奈佐利,利奈唑胺;利奈唑胺 USP标准品;利奈唑胺(斯沃);利奈唑胺标准品;利奈唑胺杂质对照品;利奈唑烷;利柰唑酮;吗啉噁酮;吗啉恶酮;吗啉恶酮 标准品;噻唑烷-2-甲酸;(S)-N-[[3-(3-氟-4-吗啉基苯基)-2-氧代-5-唑烷基]甲基]乙酰胺;利奈唑;利奈唑胺,吗啉恶酮,雷奈佐利;利奈唑胺中间体;利奈唑酮;吗啉恶酮,雷奈佐利;N-[[(5S)-3-[3-氟-4-(4-吗啉基)苯基] -2-氧代-5-恶唑烷基]甲基]乙酰胺;(S)-N-[[3-(3-氟-4-吗啉基苯基)-2-氧代-5-噁唑烷基]甲基]乙酰胺;利奈唑胺(游离);利奈唑胺杂质 |
| 英文别名 |
Linezolid;Linezolid and InterMediate;N-{[(5S)-3-[3-fluoro-4-(Morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]Methyl}acetaMide;(S)-N-((3-(3-fluoro-4-Morpholinophenyl)-2-oxooxazolidin-5-yl)Methyl)acetaMide;Linezolid (PNU-100766);Linezolid API;Ray Nizzoli;Linezolid (S)-N-[[3-(3-Fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide;Linezolid (200 mg);N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;N-[3-[3-Fluoro-4-(4-Morpholinyl)phenyl]-2-oxooxazolidin-5(S)-ylMethyl]acetaMide (Zyvox);Linezlid;Zyvox;Zyvoxa;Zyvoxam;Zyvoxid;N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;PNU-100766;U-100766;(S)-N-[[3-(3-Fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide;Linox;U 100766;Linospan;LINEZOLIDE;PNU 100766;C16H20FN3O4;ISQ9I6J12J;N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide;TYZROVQLWOKYKF-ZDUSSCGKSA-N;Linezolid, 98%;CPD000466335;(S)-N-[[3-(3-fluoro-4-morpholinylphe;NCGC00263531-05;N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide;NDA 21-132 Zyvox oral suspension (linzolid oral suspension);D00947;Acetamide, N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (S)-;AB00639994-09;Linezolid (Zyvox);MLS001424075;HMS3260C14;MFCD00937825;BCP9000855;Linezolidum;N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide(linezolid);LINEZOLID [ORANGE BOOK];LINEZOLID [USAN];LINEZOLID [WHO-DD];HMS2089K06;LINEZOLID [MART.];LINEZOLID (USP MONOGRAPH);LINEZOLID [USP-RS];LINEZOLID [INN];SR-01000759376-5;LINEZOLID (MART.);(S)-N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide;AB00639994-06;HSDB 7478;BDBM50116067;GTPL10827;BIDD:GT0404;NDA 21-131 Zyvox for injection (linezolid injection);SR-01000759376;N-[[(5S)-3-(3-fluoranyl-4-morpholin-4-yl-phenyl)-2-oxidanylidene-1,3-oxazolidin-5-yl]methyl]ethanamide;Linezolid & VRC3375;LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER;Zivoxid;Linezolid [USAN:INN:BAN];U-100,766;BCP05586;Benzotriazol-2-yl-acetonitrile;N-((S)-2-oxo-3-(S)-2,3,3a,4-tetrahydro-1H-benzo[b]pyrrolo[1,2-d][1,4]oxazin-7-yl-oxazolidin-5-ylmethyl)-acetamide;LINEZOLID [HSDB];KS-1178;NCGC00263531-10;CS-0756;AB00639994-08;N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide;SCHEMBL5027;AKOS016340522;C08146;N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide;MLS000759444;N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide;NDA 21-130 Zyvox (linezolid tablets);ZLD;N-[(R)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide;DTXCID3026489;Linezolid, >=98% (HPLC);N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide;CAS-165800-03-3;SR-01000759376-11;Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpho... |